Prospects for Therapies in Osteoarthritis

Area of Science:

• Rheumatology
• Pharmacology
• Biomedical Engineering

Background:

• Osteoarthritis (OA) is a widespread, chronic disease impacting millions globally.
• Current OA treatments, including conventional drugs, offer limited efficacy and side effects.
• Novel pharmacological therapies targeting bone, cartilage, synovium, and nerves are needed.

Purpose of the Study:

• To review the current landscape of osteoarthritis pharmacotherapy.
• To evaluate the progress and challenges in developing disease-modifying osteoarthritis drugs (DMOADs).
• To identify key considerations for future clinical trials of OA therapies.

Main Methods:

• Literature review of recent studies on OA pharmacological treatments.
• Analysis of therapeutic targets in OA, including bone, cartilage, synovium, and nerves.
• Evaluation of outcomes from recent DMOAD trials.

Main Results:

• Despite efforts, developing effective OA therapies has faced significant challenges.
• Some DMOAD candidates have shown preliminary promise in targeting structural pathologies.
• Limited success highlights the complexity of OA and the need for refined therapeutic strategies.

Conclusions:

• There is an unmet need for effective pharmacological treatments for osteoarthritis.
• Disease-modifying osteoarthritis drugs (DMOADs) represent a promising avenue, though challenges remain.
• Future research and clinical trials must incorporate lessons learned to advance OA management.